Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Ebix (EBIX) -2.7% after SA contributor Gotham City Research accuses the insurance software maker of a long list of accounting misdeeds. Among other things, Gotham City notes the existence of a $65.8M related party loan by Ebix's Singapore unit, claims Ebix's Australian revenue (as disclosed in Australian filings) is a fraction of what's claimed in SEC filings, and estimates 20%-40% of accounts receivable "seem of dubious quality." The SEC has already launched a probe of Ebix's accounting.
Is EBIX after A Solid Pop Up? Find Out Here
Repros Therapeutics (RPRX) +33.1% premarket on news its Androxal Phase 3 program has been given a receipt of written guidance from the FDA, effectively a notice that the FDA has accepted its study plans. Androxal is a treatment to normalize testosterone and luteinizing hormone levels in men.
How Should Investors Trade RPRX After The recent Earnings Report? Find Out Here
WSP Holdings (WH) +81.2% premarket after agreeing to be taken private by HDS Investments in a deal that values the Chinese maker of seamless casing, tubing and drill pipes used in energy exploration at $65.6M.
Why Should Investors Consider Buying WH Now? Find Out Here
Best Buy (BBY) suddenly looks just a little bit more favorable to analysts as it benefits from mobile phone/tablet competition and gets subtle backing from consumer electronics firms anxious to limit Amazon's pricing power. Also to its credit, a new management team lead by CEO Hubert Joly has its hands firmly on the rudder. BBY -0.6% premarket, +46% YTD to complicate Richard Schulze's buyout bid.
Is BBY Still a Buy After The Recent momentum? Find Out Here
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)